v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
OPERATING EXPENSES        
Research and development $ 2,558,000 $ 2,593,000 $ 5,145,000 $ 5,018,000
General and administrative 1,592,000 3,071,000 3,192,000 5,708,000
Total operating expense 4,150,000 5,664,000 8,337,000 10,726,000
Loss from operations (4,150,000) (5,664,000) (8,337,000) (10,726,000)
OTHER INCOME (EXPENSE), NET        
Change in fair value of other liabilities and derivatives     47,000 16,000
Grant income 50,000
Other income (expense), net 31,000 (22,000) 104,000 (32,000)
Total other income (expense), net (5,000) (93,000) 78,000 (90,000)
LOSS BEFORE INCOME TAXES (4,155,000) (5,757,000) (8,259,000) (10,816,000)
Income tax provision (5,000) (4,000) (9,000) (7,000)
NET LOSS (4,160,000) (5,761,000) (8,268,000) (10,823,000)
Net loss attributable to noncontrolling interest (46,000) (122,000)
NET LOSS ATTRIBUTABLE TO CONTROLLING INTEREST (4,160,000) (5,715,000) (8,268,000) (10,701,000)
Deemed dividend on warrants (309,000)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (4,160,000) $ (5,715,000) $ (8,577,000) $ (10,701,000)
Net loss per share, basic $ (2.94) $ (31.75) $ (8.31) $ (66.47)
Net loss per share, diluted $ (2.94) $ (31.75) $ (8.31) $ (66.47)
Weighted average common shares outstanding, basic 1,416 180 1,032 161
Weighted average common shares outstanding, diluted 1,416 180 1,032 161
Nonrelated Party [Member]        
OTHER INCOME (EXPENSE), NET        
Interest expense $ (29,000) $ (29,000) $ (62,000) $ (63,000)
Change in fair value of other liabilities and derivatives (1,000) (18,000) 44,000 14,000
Related Party [Member]        
OTHER INCOME (EXPENSE), NET        
Interest expense (6,000) (23,000) (11,000) (61,000)
Change in fair value of other liabilities and derivatives $ (1,000) $ 3,000 $ 2,000